NSAID use following skeletal trauma

British Journal of General Practice

Volumn 53, Issue 490, 2003, Pages 407-408

  Murnaghan, J M ^a   Marsh, D R ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIA; ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; BONE INJURY; DIAPHYSIS; DRUG INDICATION; DRUG USE; FRACTURE; FRACTURE HEALING; FRACTURE NONUNION; HETEROTOPIC OSSIFICATION; HUMAN; LETTER; ORTHOPEDIC SURGERY; QUESTIONNAIRE; RISK; SIDE EFFECT; SPINE FUSION;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FEMALE; FRACTURE HEALING; FRACTURES, BONE; FRACTURES, UNUNITED; HUMANS; MALE;

EID: 0037687500     PISSN: 09601643     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (8)

1. Van Staa TP, Dennison EM, Leufkens HG, Cooper C. Epidemiology of fractures in England and Wales. Bone 2001; 29(6):517-522.
2. Fitzgerald GA. Parsing an enigma: The pharmacodynamics of aspirin resistance. Lancet 2003; 361(9357):542-544.
3. Glassman SD, Rose SM, Dimar JR, et al. The effect of postoperative non-steroidal anti-inflammatory drug administration on spinal fusion. Spine 1998; 23(7):834-838.
4. Giannoudis PV, MacDonald DA, Matthews SJ, et al. Non-union of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg 2000; 82(5):655-658.
5. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long bone non-union. [Abstract.] Eighteenth Annual Meeting of the Orthopaedic Trauma Association, 1 November 2002.
6. Heckman JD, Sarasohn-Kahn J. The economics of treating tibia fractures. The cost of delayed unions. Bull Hosp Jt Dis 1997; 56(1):63-72.
7. Koki AT, Masferrer JL. Celecoxib: A specific COX-2 inhibitor with anticancer properties. Cancer Control 2002; 9(2 Suppl): 28-35.
8. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18(55): 7908-7916.